Via this meta-analysis, researchers assessed the activity and efficacy of the following strategies to treat patients with melanoma brain metastases: targeted therapies (TT), combination immunotherapy (CMI), and monoimmunotherapy (MI) in combination with radiotherapy (CRI) or not in combination.
Scientific Publications
Melanoma Journal Articles for July 2019
Please click on the link to see a list of melanoma journal citations the crossed the MRV desk this month.
Pembrolizumab vs ipilimumab in advanced melanoma (KEYNOTE-006): Post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study
Researchers describe findings after a 5-year follow-up among participants of an open-label, multicenter, randomized, controlled, phase 3 study assessing pembrolizumab vs ipilimumab in patients with advanced melanoma.
Melanoma Journal Articles for June 2019
Please click on the link to see a list of melanoma journal citations the crossed the MRV desk this month.